Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial ...
Company Announcement First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen Financial guidance updated Copenhagen, Denmark; November 14, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the …